CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 77 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,532,810 | -25.0% | 1,188,225 | 0.0% | 0.01% | -18.2% |
| Q2 2023 | $2,043,747 | +13.9% | 1,188,225 | 0.0% | 0.01% | -8.3% |
| Q1 2023 | $1,794,220 | -11.8% | 1,188,225 | -6.5% | 0.01% | +20.0% |
| Q4 2022 | $2,033,440 | +10.3% | 1,270,900 | 0.0% | 0.01% | -9.1% |
| Q3 2022 | $1,843,000 | -20.8% | 1,270,900 | 0.0% | 0.01% | -69.4% |
| Q2 2022 | $2,326,000 | – | 1,270,900 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 524,763 | $7,924,000 | 3.84% |
| Congress Park Capital LLC | 123,311 | $1,862,000 | 2.05% |
| Perceptive Advisors | 2,911,715 | $43,588,000 | 1.66% |
| RTW INVESTMENTS, LP | 908,586 | $13,720,000 | 1.28% |
| HAMILTON LANE ADVISORS LLC | 68,753 | $1,038,000 | 0.91% |
| HARBOURVEST PARTNERS LLC | 79,193 | $1,196,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 273,151 | $4,125,000 | 0.46% |
| Exane Asset Management | 50,000 | $755,000,000 | 0.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 622,548 | $9,400,000 | 0.38% |
| Cormorant Asset Management, LP | 296,712 | $4,480,000 | 0.36% |